U.S., Dec. 5 -- ClinicalTrials.gov registry received information related to the study (NCT07263906) titled 'Clinical Study of LILRA6 CAR-T for the Treatment of R/R Acute Myeloid Leukemia' on Nov. 24.
Brief Summary: This study aims to evaluate the safety and efficacy of LILRA6-directed chimeric antigen receptor T cells (LILRA6 CAR-T cells) in patients with refractory or relapsed acute myeloid leukemia(AML).
Study Start Date: Dec. 01
Study Type: INTERVENTIONAL
Condition:
Refractory Acute Myeloid Leukemia
Recurrent Acute Myeloid Leukemia
Intervention:
BIOLOGICAL: Anti-LILRA6 CAR-T cells
lentiviral vector-transducted peripheral blood-derived T cells to express anti-LILRA6 CAR
Recruitment Status: RECRUITING
Sponsor: Second Affiliated H...